General Information of the Compound
| Compound ID |
CP0373376
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-2-[(2S,3S)-3-{4-[5-(3-Cyano-4-methoxy-benzyl)-2-ethyl-2H-pyrazol-3-yl]-piperidin-1-ylmethyl}-4-(3-fluoro-phenyl)-pyrrolidin-1-yl]-3-methyl-butyric acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H44FN5O3
|
||||||||||||||||||
| Molecular Weight |
601.767
|
||||||||||||||||||
| Canonical SMILES |
CCn1nc(Cc2ccc(OC)c(c2)C#N)cc1C1CCN(C[C@H]2CN(C[C@@H]2c2cccc(F)c2)[C@H](C(C)C)C(O)=O)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H44FN5O3/c1-5-41-32(18-30(38-41)16-24-9-10-33(44-4)27(15-24)19-37)25-11-13-39(14-12-25)20-28-21-40(34(23(2)3)35(42)43)22-31(28)26-7-6-8-29(36)17-26/h6-10,15,17-18,23,25,28,31,34H,5,11-14,16,20-22H2,1-4H3,(H,42,43)/t28-,31+,34+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RLMKPCDGHIJQNP-LKQHQURMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound